MedPath

卫材(辽宁)制药有限公司

Ownership
-
Established
2011-12-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

125

NMPA:125

Drug Approvals

Cerebroprotein Hydrolysate

Product Name
脑蛋白水解物
Approval Number
国药准字H21023426
Approval Date
Sep 27, 2024
NMPA

Montmorillonite Powder

Product Name
蒙脱石散
Approval Number
国药准字H20074095
Approval Date
May 11, 2022
NMPA

Thyroid Tablets

Product Name
甲状腺片
Approval Number
国药准字H21021504
Approval Date
Jun 4, 2020
NMPA

红药片

Approval Number
国药准字Z21021086
Approval Date
Jun 4, 2020
NMPA

Pancreatin Enteric-coated Tablets

Product Name
胰酶肠溶片
Approval Number
国药准字H21021500
Approval Date
Jun 4, 2020
NMPA

Pepisin Granules

Product Name
胃蛋白酶颗粒
Approval Number
国药准字H21021466
Approval Date
Jun 4, 2020
NMPA

Saccharated Pepsin

Product Name
含糖胃蛋白酶
Approval Number
国药准字H21021495
Approval Date
Jun 4, 2020
NMPA

Tramadol Hydrochoride Tablets

Product Name
盐酸曲马多片
Approval Number
国药准字H10950146
Approval Date
Jun 4, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H21021465
Approval Date
Jun 4, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z21021901
Approval Date
Jun 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.